Prospector Partners LLC Gsk PLC Transaction History

Prospector Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $5.23 Million - $5.91 Million	-138,400 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$39.75 - $42.69 $67,575 - $72,573	1,700 Added 1.24%	138,400 $5.56 Million
Q2 2018 Aug 14, 2018	SELL	$39.61 - $42.76 $43,571 - $47,036	-1,100 Reduced 0.8%	136,700 $5.51 Million
Q1 2018 May 15, 2018	SELL	$36.18 - $40.15 $86,832 - $96,360	-2,400 Reduced 1.71%	137,800 $5.38 Million
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $427,614 - $506,990	-12,100 Reduced 7.94%	140,200 $4.97 Million
Q3 2017 Nov 14, 2017	SELL	$39.44 - $41.55 $110,432 - $116,339	-2,800 Reduced 1.81%	152,300 $6.18 Million
Q2 2017 Aug 14, 2017	BUY	N/A	155,100	155,100 $6.69 Million

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $75.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Prospector Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Prospector Partners LLC with notifications on news.